Table of Contents
Chapter 1. Executive Summary
Chapter 2. Market Trends, By Patient Demographics
2.1. Prevalence of Different Cancer Types in the U.S.
2.1.1. Breast Cancer
2.1.2. Prostate Cancer
2.1.3. Lung & Bronchus Cancer
2.1.4. Anal Cancer
2.1.5. Vulvar Cancer
2.1.6. Head & Neck Cancers
2.1.7. Rectal Cancer
2.1.8. Colon Cancer
2.1.9. Melanoma Cancer
2.1.10. Bladder Cancer
2.1.11. Non-Hodgkin Lymphoma
2.1.12. Kidney Cancer
2.1.13. Thyroid Cancer
2.1.14. Liver
2.1.15. Stomach
2.1.16. Others
2.2. Prevalence of Different Cancer Types in the U.S.
2.3. Incidence and Mortality Rates of Different Cancer Types in the U.S. in 2024
2.4. Expected Cancer Incidence in the U.S. for 2024 (by States)
2.5. Number of Patients Opting for Radiation Therapy and Suffering From Radiodermatitis in the U.S. in 2024
2.6. Grades of Radiodermatitis for Different Cancer Types
2.6.1. Grade 0
2.6.2. Grade 1
2.6.3. Grade 2
2.6.4. Grade 3
2.6.5. Grade 4
2.7. Characterization of Radiodermatitis for Cancer Using Clinical Parameters
2.8. Facility Types for Radiation Therapy (for Different Types of Cancer in the U.S.)
2.8.1. Hospital-based Radiotherapy Centers
2.8.2. Independent Radiotherapy Centers
2.9. Average Product Cost for Radiodermatitis Treatment
2.9.1. Topical Product Category
2.9.2. Dressings Product Category